Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2020-12-09 2020-12-01
Drug Identification Number 02283794 02283794
Brand name MYLAN-CILAZAPRIL MYLAN-CILAZAPRIL
Common or Proper name CILAZAPRIL CILAZAPRIL
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients CILAZAPRIL CILAZAPRIL
Strength(s) 5.0MG 5.0MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100BT 100BT
ATC code C09AA C09AA
ATC description ACE INHIBITORS, PLAIN ACE INHIBITORS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2021-01-06 2021-01-06
Actual start date
Estimated end date 2021-03-02 2021-03-15
Actual end date 2020-12-08
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments